BCL2L11 and neoplasm: MET inhibition led to sustained tumor regression, and Western blot analysis revealed that MET inhibition alone induced up-regulation of the proapoptotic Bcl2-like protein 11 (BIM) in the tumor xenografts (Fig. 1C).